These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37376113)

  • 1. Development of a Gene and Nucleic Acid Delivery System for Skeletal Muscle Administration via Limb Perfusion Using Nanobubbles and Ultrasound.
    Sekine S; Mayama S; Nishijima N; Kojima T; Endo-Takahashi Y; Ishii Y; Shiono H; Akiyama S; Sakurai A; Sashida S; Hamano N; Tada R; Suzuki R; Maruyama K; Negishi Y
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
    Negishi Y; Ishii Y; Shiono H; Akiyama S; Sekine S; Kojima T; Mayama S; Kikuchi T; Hamano N; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
    Mol Pharm; 2014 Mar; 11(3):1053-61. PubMed ID: 24433046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment.
    Negishi Y; Ishii Y; Nirasawa K; Sasaki E; Endo-Takahashi Y; Suzuki R; Maruyama K
    Methods Mol Biol; 2018; 1687():185-192. PubMed ID: 29067664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
    Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
    Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of naked DNA uptake and expression.
    Wolff JA; Budker V
    Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional efficacy of dystrophin expression from plasmids delivered to mdx mice by hydrodynamic limb vein injection.
    Zhang G; Wooddell CI; Hegge JO; Griffin JB; Huss T; Braun S; Wolff JA
    Hum Gene Ther; 2010 Feb; 21(2):221-37. PubMed ID: 19788386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA.
    Liang KW; Nishikawa M; Liu F; Sun B; Ye Q; Huang L
    Gene Ther; 2004 Jun; 11(11):901-8. PubMed ID: 14985786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing regimen has a significant impact on the efficiency of morpholino oligomer-induced exon skipping in mdx mice.
    Malerba A; Thorogood FC; Dickson G; Graham IR
    Hum Gene Ther; 2009 Sep; 20(9):955-65. PubMed ID: 19469709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
    Maruyama R; Aoki Y; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():365-379. PubMed ID: 30171554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle.
    Miyatake S; Mizobe Y; Tsoumpra MK; Lim KRQ; Hara Y; Shabanpoor F; Yokota T; Takeda S; Aoki Y
    Mol Ther Nucleic Acids; 2019 Mar; 14():520-535. PubMed ID: 30763772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
    Maruyama R; Yokota T
    Methods Mol Biol; 2021; 2224():203-214. PubMed ID: 33606217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in
    Gan L; Wu LCL; Wood JA; Yao M; Treleaven CM; Estrella NL; Wentworth BM; Hanson GJ; Passini MA
    Mol Ther Nucleic Acids; 2022 Dec; 30():17-27. PubMed ID: 36189424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical impedance myography detects dystrophin-related muscle changes in mdx mice.
    Hiyoshi T; Zhao F; Baba R; Hirakawa T; Kuboki R; Suzuki K; Tomimatsu Y; O'Donnell P; Han S; Zach N; Nakashima M
    Skelet Muscle; 2023 Nov; 13(1):19. PubMed ID: 37980539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy.
    Gushchina LV; Vetter TA; Frair EC; Bradley AJ; Grounds KM; Lay JW; Huang N; Suhaiba A; Schnell FJ; Hanson G; Simmons TR; Wein N; Flanigan KM
    Mol Ther Nucleic Acids; 2022 Dec; 30():479-492. PubMed ID: 36420217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy.
    Echigoya Y; Nakamura A; Nagata T; Urasawa N; Lim KRQ; Trieu N; Panesar D; Kuraoka M; Moulton HM; Saito T; Aoki Y; Iversen P; Sazani P; Kole R; Maruyama R; Partridge T; Takeda S; Yokota T
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4213-4218. PubMed ID: 28373570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy.
    Moulton HM; Moulton JD
    Biochim Biophys Acta; 2010 Dec; 1798(12):2296-303. PubMed ID: 20170628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD.
    Akpulat U; Wang H; Becker K; Contreras A; Partridge TA; Novak JS; Cirak S
    Mol Ther Nucleic Acids; 2018 Dec; 13():534-542. PubMed ID: 30396145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular Dystrophy.
    Benny Klimek ME; Vila MC; Edwards K; Boehler J; Novak J; Zhang A; Van der Meulen J; Tatum K; Quinn J; Fiorillo A; Burki U; Straub V; Lu QL; Hathout Y; van Den Anker J; Partridge TA; Morales M; Hoffman E; Nagaraju K
    J Neuromuscul Dis; 2021; 8(s2):S369-S381. PubMed ID: 34569970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy.
    Malerba A; Kang JK; McClorey G; Saleh AF; Popplewell L; Gait MJ; Wood MJ; Dickson G
    Mol Ther Nucleic Acids; 2012 Dec; 1(12):e62. PubMed ID: 23250360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene.
    Echigoya Y; Lim KRQ; Melo D; Bao B; Trieu N; Mizobe Y; Maruyama R; Mamchaoui K; Tanihata J; Aoki Y; Takeda S; Mouly V; Duddy W; Yokota T
    Mol Ther; 2019 Nov; 27(11):2005-2017. PubMed ID: 31416775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.